Hints and tips:
Related Special Reports
...Investors will still have to wait until at least 2026 for an approved oncology product....
...Other life sciences companies have found partners to help them navigate the NHS and overcome its challenges....
...While Point has two drugs in late-stage trials, Raffat said they were licensed to Lantheus Medical Imaging, which is paying royalties of 15 per cent to 20 per cent to Point....
...The same concerns have plagued other drugmakers whose sales surged during the pandemic, such as Moderna and Pfizer’s partner BioNTech....
...Galbraith did not comment on whether AstraZeneca had bid to partner on the next drugs in the pipeline....
...He was asked whether he had shared a meal of “pasta pesto and a bolognaise” with his partner but denied this....
...The start-up was founded in 2019 by six immunologists from King’s College London, University College London and Hannover Medical School....
...It rejected Illumina’s claim that the acquisition would accelerate the rollout of Grail’s oncology tests and save lives, noting the company’s projections were “vague, self-serving, and unsupported”....
...The US drugmaker was reportedly in talks with oncology-focused Seagen about a potential deal last year but did not move forward with a transaction....
...It declined to challenge Amazon’s $3.9bn acquisition of healthcare chain One Medical....
...Ken Keller, chief executive of AZ’s Japanese partner on the drug, deliberately stood apart from his team at the American Society of Clinical Oncology meeting to see the mood of the crowd....
...Harbour BioMed, which focuses on immuno-oncology, sold its Suzhou factory to Wuxi Vaccines and has cut its pipeline of drugs....
...Standout Intuitive SurgicalO: 7; L: 8; I: 8; Total: 23In collaboration with law firm Yulchon, the South Korean legal team at the international healthcare and medical devices business has created a new compliance...
...A number of Chinese tech names have listed in Zurich, including lithium battery producers Gotion High-Tech and Sunwoda Electronic, medical device maker Lepu Medical Technology Beijing, and hand tool manufacturer...
...However, Paxlovid will be covered by medical insurance until March 31 under the terms of an emergency deal....
...“The Norfolk Southern resolution aligns with [Impact partner] YWCA’s longtime advocacy for economic security for women and families focused on paid family and medical leave, paid sick leave and safe leave...
...It has also narrowed its focus on two therapeutic areas: oncology and neurology....
...It is “the first cloud-based AI medical device to actually be written from within the NHS, to be deployed across the NHS for free”, he said. The impact on productivity is clear, he suggests....
...But Jallal knew that if Immunocore was to commercialise this drug on its own, without a large pharmaceutical partner, it would need even more money....
...That assessment was challenged by Northwest’s management and the trial results were subsequently reviewed much more favourably in a medical journal article published in November....
...SeaGen — formerly known as Seattle Genetics — has four approved oncology treatments....
...medical officer....
...But since medical guidelines recommend patients take antiviral drugs within five days of infection, they did not use the medication they had. “We wanted to use antivirals but don’t dare to,” Wu said....
...“Now we have a partner with a global infrastructure and oncology expertise that enables us to deliver momelotinib to patients as quickly as possible and on a global scale,” he said....
...The BrightDrop legal team worked with their business partners on adapting the product for a commercial audience....
International Edition